At the conclusion of the activity, participants will be able to:
- Evaluate clinical data regarding the use of biomarkers in qualifying patients for specific oncolytic therapies
- Interpret tumor pathology reports to facilitate evidence-based treatment across malignancies
- Summarize diagnostic and treatment-related data relevant to multidisciplinary care
- Evaluate the most relevant data regarding the current and evolving role of genomic assays in cancer management.